126 related articles for article (PubMed ID: 38885911)
1. Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS.
Yang J; Shi C; Cheng Y; Zhu Y; Yang X; Liang Y; Liang H; Lin Q; Li M; Xun J; Liu J; Yin C; Qi J; Zhu H
Eur J Pharm Biopharm; 2024 Jun; ():114353. PubMed ID: 38885911
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.
Wang P; Lu P; Qu X; Shen Y; Zeng H; Zhu X; Zhu Y; Li X; Wu H; Xu J; Lu H; Ma Z; Zhu H
Sci Rep; 2017 Aug; 7(1):9451. PubMed ID: 28842560
[TBL] [Abstract][Full Text] [Related]
3. EK-16A liposomes enhance HIV replication in ACH2 or J-Lat 10.6 cell engrafted NSG mice.
Lu P; Yang J; Yang X; Liang Z; Wang J; Wang Y; Zhao L; Pan H; Shen X; Zhu Y; Xun J; Lu H; Zhu H
Nanotheranostics; 2022; 6(3):325-336. PubMed ID: 35721664
[No Abstract] [Full Text] [Related]
4. Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.
Yang H; Li X; Yang X; Lu P; Wang Y; Jiang Z; Pan H; Zhao L; Zhu Y; Khan IU; Shen Y; Lu H; Zhang T; Jiang G; Ma Z; Wu H; Zhu H
Antiviral Res; 2019 Sep; 169():104555. PubMed ID: 31295520
[TBL] [Abstract][Full Text] [Related]
5. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.
Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex.
Zhang J; Peng Q; Shi S; Zhang Q; Sun X; Gong T; Zhang Z
Int J Nanomedicine; 2011; 6():3405-14. PubMed ID: 22267925
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 Antagonist Obatoclax Reactivates Latent HIV-1 via the NF-κB Pathway and Induces Latent Reservoir Cell Apoptosis in Latently Infected Cells.
Zhou C; Li T; Xia M; Wu Z; Zhong X; Li A; Rashid HK; Ma C; Zhou R; Duan H; Zhang X; Peng J; Li L
ACS Infect Dis; 2023 Nov; 9(11):2105-2118. PubMed ID: 37796279
[TBL] [Abstract][Full Text] [Related]
8. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
[TBL] [Abstract][Full Text] [Related]
9. Mixed surfactant based (SNEDDS) self-nanoemulsifying drug delivery system presenting efavirenz for enhancement of oral bioavailability.
Senapati PC; Sahoo SK; Sahu AN
Biomed Pharmacother; 2016 May; 80():42-51. PubMed ID: 27133038
[TBL] [Abstract][Full Text] [Related]
10. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
[TBL] [Abstract][Full Text] [Related]
11. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review.
Debrabander Q; Hensley KS; Psomas CK; Bramer W; Mahmoudi T; van Welzen BJ; Verbon A; Rokx C
J Virus Erad; 2023 Sep; 9(3):100342. PubMed ID: 37663575
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Optimization of Rivaroxaban by Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Enhanced Oral Bioavailability and No Food Effect.
Xue X; Cao M; Ren L; Qian Y; Chen G
AAPS PharmSciTech; 2018 May; 19(4):1847-1859. PubMed ID: 29637496
[TBL] [Abstract][Full Text] [Related]
14. A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice.
Knights HDJ
AIDS Res Treat; 2017; 2017():8239428. PubMed ID: 28465838
[TBL] [Abstract][Full Text] [Related]
15. Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV.
Ghofrani J; Bowen A; Chen J; Balakrishnan PB; Powell AB; Cherukula K; Cruz CRY; Jones RB; Lynch RM; Sweeney EE; Fernandes R
Int J Nanomedicine; 2023; 18():4055-4066. PubMed ID: 37520301
[TBL] [Abstract][Full Text] [Related]
16. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
Macedo AB; Levinger C; Nguyen BN; Richard J; Gupta M; Cruz CRY; Finzi A; Chiappinelli KB; Crandall KA; Bosque A
J Virol; 2022 Aug; 96(15):e0037222. PubMed ID: 35867565
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability and anti-hyperuricemic activity of liquiritin via a self-nanoemulsifying drug delivery system.
Wei C; Wang Q; Weng W; Adu-Frimpong M; Toreniyazov E; Ji H; Xu X; Yu J
J Sci Food Agric; 2022 Mar; 102(5):2032-2040. PubMed ID: 34558068
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex.
Zhang J; Wen X; Dai Y; Xia Y
Int J Nanomedicine; 2019; 14():7095-7106. PubMed ID: 31564867
[TBL] [Abstract][Full Text] [Related]
19. Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis.
Khattab A; Hassanin L; Zaki N
AAPS PharmSciTech; 2017 Jul; 18(5):1657-1672. PubMed ID: 27677262
[TBL] [Abstract][Full Text] [Related]
20. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment.
Usta DY; Timur B; Teksin ZS
Eur J Pharm Sci; 2022 Jul; 174():106159. PubMed ID: 35263632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
